DUBLIN–(BUSINESS WIRE)–The “Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. The report provides in depth analysis on Hepatitis B Virus Surface Antigen (HBsAg) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by … [Read more…]

GENEVA–(BUSINESS WIRE)–iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumors, announced today that it will present Phase Ib data on its lead pipeline asset, IOA-244, the highly differentiated novel phosphoinositide 3-kinase delta (PI3Kδ) inhibitor, at the 2022 ASCO (American Society of Clinical Oncology) Annual Meeting, taking place June 3-7 in Chicago. … [Read more…]

MONTREAL–(BUSINESS WIRE)–#CFO–Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today announces the appointment of Glenn S. Vraniak to the position of Chief Financial Officer (CFO), effective immediately. Mr. Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences industry. Before … [Read more…]

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European organization, including commercial and clinical teams, and this new location … [Read more…]

First-of-its-kind partnership highlights how startups can work with established industry leaders to feed the world SAN FRANCISCO & CHICAGO–(BUSINESS WIRE)–Eat Just, Inc., a company that applies cutting-edge science and technology on a mission to create healthier, more sustainable foods, announced today that its GOOD Meat division has entered into a joint development agreement with ADM, … [Read more…]

MILAN–(BUSINESS WIRE)–Deenova today announced that it continued its last 2 years market dominance in France with another net new RESAH competitive award for its D3 ACCED mechatronic solutions at Centre Hospitalier Hazebrouck near Dunkerque. Separately, Deenova is pleased to simultaneously announce add-on sales of 4 ASTUS cabinets to existing Deenova customer Centre Hospitalier François Quesnay … [Read more…]

SINGAPORE–(BUSINESS WIRE)–Vonage (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, has been chosen by Doctor Anywhere, a regional omnichannel healthcare company headquartered in Singapore, to deliver timely and effective digital healthcare solutions across Southeast Asia using Vonage’s Video API. Doctor Anywhere – a tech-enabled, omnichannel healthcare service provider – … [Read more…]

Podium presentation highlights significant transduction and transgene expression in pharmacokinetic studies in mice, non-human primates and a humanized liver model Poster presentation focuses on pharmacology, toxicology and safety studies Poster presentation focuses on the development of a novel transduction assay to evaluate in-vitro relative Infectivity MILPITAS, Calif.–(BUSINESS WIRE)–#ASCCT22–ASC Therapeutics, a privately held biopharmaceutical company pioneering … [Read more…]

First Study from CANbridge UMass Collaboration Shows Novel Gene Therapy Holds Promise for Spinal Muscular Atrophy Clinical Applications BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a leading China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced the presentation of the initial data from … [Read more…]

First known bovine model used to demonstrate safety and efficacy in gene replacement therapy MSUD is a severe genetic disease with liver transplantation or dietary restriction as the only treatments currently available MILPITAS, Calif.–(BUSINESS WIRE)–#ASCCT22–ASC Therapeutics in partnership with the University of Massachusetts Medical School (UMMS) and the Clinic for Special Children (CSC), will present … [Read more…]